Primary neuroendocrine carcinoma of the breast, which chemotherapy?
El Hassani
L K
LK
Bensouda
Y
Y
M'Rabti
H
H
Boutayeb
S
S
Kamouni
M
M
Gamra
L
L
Errihani
H
H
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000473:pathology; D018278:Carcinoma, Neuroendocrine / Q000188:drug therapy* / Q000473:pathology; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D017809:Fatal Outcome; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006801:Humans; D007150:Immunohistochemistry; D017211:Treatment Failure
D004317:Doxorubicin; D003520:Cyclophosphamide; D005472:Fluorouracil